Cargando…

Associations between the expression of SCCA, MTA1, P16, Ki-67 and the infection of high-risk HPV in cervical lesions

The application of detection technologies for human papillomavirus (HPV) has increased the resection rate for cervical intraepithelial neoplasia and early cervical cancer types. However, a large number of patients still present with advanced cervical cancer upon diagnosis. Therefore, to find a marke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Cuina, Zhao, Fangfei, Wan, Chongyang, He, Yanfang, Chen, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286137/ https://www.ncbi.nlm.nih.gov/pubmed/32566016 http://dx.doi.org/10.3892/ol.2020.11634

Ejemplares similares

HPV genotyping and p16/Ki-67 test significantly improve detection rate of high-grade cervical squamous intraepithelial lesion
por: Lewitowicz, Piotr, et al.
Publicado: (2019)

Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1–2 lesions
por: Li, Yuejie, et al.
Publicado: (2019)

Adoptive TIL in HPV-negative oral scca
por: Leidner, Rom, et al.
Publicado: (2015)

Risk of progression of early cervical lesions is associated with integration and persistence of HPV-16 and expression of E6, Ki-67, and telomerase
por: Vega-Peña, Arianna, et al.
Publicado: (2013)

The Expression of Testin, Ki-67 and p16 in Cervical Cancer Diagnostics
por: Popiel-Kopaczyk, Aneta, et al.
Publicado: (2023)

Comparison of Ki67 index and P16 expression in different grades of cervical squamous intraepithelial lesions
por: Hosseini, Maryam Sadat, et al.
Publicado: (2023)

Ki-67 and P16 proteins in cervical cancer and precancerous lesions of young women and the diagnostic value for cervical cancer and precancerous lesions
por: Shi, Qin, et al.
Publicado: (2019)

Application of p16/Ki-67 dual-staining cytology in cervical cancers
por: Yu, Li, et al.
Publicado: (2019)

The Role of p16/Ki67 Dual Staining in Cervical Cancer Screening
por: Dovnik, Andraž, et al.
Publicado: (2023)

Evaluation of Ki67, p16 and CK17 Markers in Differentiating Cervical Intraepithelial Neoplasia and Benign Lesions
por: Sari Aslani, Fatemeh, et al.
Publicado: (2013)

The Utility of p16INK4a and Ki-67 as a Conjunctive Tool in Uterine Cervical Lesions
por: Lee, Sangho, et al.
Publicado: (2012)

Frequency of Chlamydia trachomatis infection in cervical intraepithelial lesions and the status of cytological p16/Ki-67 dual-staining
por: Robial, R., et al.
Publicado: (2017)

The p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions
por: Magkana, Maria, et al.
Publicado: (2021)

Evaluation of the p16 and Ki-67 Biomarkers as Predictors of the Recurrence of Premalignant Cervical Cancer Lesions after LEEP Conization
por: Leite, Paulo Macêdo de Oliveira, et al.
Publicado: (2017)

Expression of Ki-67 and P16 are related with HPV in squamous cell carcinoma of the external auditory canal
por: Pan, Wei, et al.
Publicado: (2022)

Role of p16/Ki-67 Dual Immunostaining in Detection of Cervical Cancer Precursors
por: Das, Diya, et al.
Publicado: (2018)

Expression of geminin, p16, and Ki67 in cervical intraepithelial neoplasm and normal tissues
por: Xing, Yan, et al.
Publicado: (2017)

Preliminary Study on the Expression of Testin, p16 and Ki-67 in the Cervical Intraepithelial Neoplasia
por: Popiel, Aneta, et al.
Publicado: (2021)

Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology
por: Mazurec, Karolina, et al.
Publicado: (2023)

p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening
por: Han, Qin, et al.
Publicado: (2020)

Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM
por: Serrano-Villar, Sergio, et al.
Publicado: (2017)

Utility of P16/INK4a and Ki-67 in Preneoplasticand Neoplastic Lesions of Cervix
por: Sangwaiya, Ashok, et al.
Publicado: (2018)

Assessment of p16 and Ki67 Immunohistochemistry Expression in Squamous Intraepithelial Lesion with Cytohistomorphological Correlation
por: Ghosh, Apurv, et al.
Publicado: (2020)

Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening
por: Harper, Diane M., et al.
Publicado: (2023)

Expression of p-16, Ki-67 and p-53 markers in dysplastic and malignant lesions of the oral cavity and oropharynx
por: Yadav, Priyanka, et al.
Publicado: (2019)

Interobserver variability and accuracy of p16/Ki-67 dual immunocytochemical staining on conventional cervical smears
por: Kloboves Prevodnik, Veronika, et al.
Publicado: (2019)

Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS
por: Zhu, Yuanhang, et al.
Publicado: (2019)

The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL
por: Possati-Resende, Júlio C., et al.
Publicado: (2015)

Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study
por: Ikenberg, Hans, et al.
Publicado: (2013)

Differential effects of periopathogens on host protease inhibitors SLPI, elafin, SCCA1, and SCCA2
por: Yin, Lei, et al.
Publicado: (2010)

Evaluation of p16/Ki-67 Dual Staining Compared with HPV Genotyping in Anal Cytology with Diagnosis of ASC-US for Detection of High-Grade Anal Intraepithelial Lesions
por: Pichon, Maxime, et al.
Publicado: (2019)

Liquid-Based Screening Tests Results: HPV, Liquid-Based Cytology, and P16/Ki67 Dual-Staining in Private-Based Opportunistic Cervical Cancer Screening
por: Trzeszcz, Martyna, et al.
Publicado: (2021)

Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years?
por: Trzeszcz, Martyna, et al.
Publicado: (2021)

Significance of Triple Detection of p16/ki-67 Dual-Staining, Liquid-Based Cytology and HR HPV Testing in Screening of Cervical Cancer: A Retrospective Study
por: Yu, Li, et al.
Publicado: (2022)

Predict the Progression of Cervical Intraepithelial Neoplasia by a Novel Marker Folate Combine with FRα, p16 and Ki-67
por: Liu, Tingting, et al.
Publicado: (2022)

P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women
por: Aromseree, Sirinart, et al.
Publicado: (2022)

The value of Ki67 for the diagnosis of LSIL and the problems of p16 in the diagnosis of HSIL
por: Liu, Jixuan, et al.
Publicado: (2022)

Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trial
por: Wright, Thomas C., et al.
Publicado: (2021)

Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China
por: Yu, Lu-Lu, et al.
Publicado: (2016)

Role of p16/INK4a and Ki-67 as specific biomarkers for cervical intraepithelial neoplasia: An institutional study
por: Hebbar, Ankitha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jqofrmea23l76a60org2p954pp